The upregulation of PD-L1 by tumor cells increases PD-L1 binding to programmed cell death protein 1 (PD1) on cytotoxic CD8+ T cells, and causes CD8+ T cell dysfunction [115]. This evidence concerns the gene CD8A and neoplasm.